Study of intellectual property laws in iranian pharmacology and drug industries

Abstract

Todays, the role of pharmaceutical and drug industries in Iranian medical economics and market are very eminent and reached to 80 billion dollars (15% of incomes in this region) because 96% of anti-microbial and anti-cancer drugs produce by Iranian companies. One of the main concerns in Iranian pharmaceutical sectors is about agreement on trade aspects of Intellectual Property laws (TRIPs. In this paper, with usage of recent findings from library references and also Iranian medical association, different aspects of Intellectual Property laws, limitations, Obstacles and other national and international effects in Iranian pharmaceutical and drugs industries will discuss. Based on results, Commitment related to proposed Intellectual Property laws by TRIPs should implement by all countries' members like Iran and all members will give commitment and respect to Patents about pharmaceutical products and produce the generic form of drugs only when the duration time of patent is finished.